<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: In both permanent and transient 3-hour middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> rat <z:hpo ids='HP_0001297'>stroke</z:hpo> models, a single intraperitoneal injection of <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 or 15 mg/kg given before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was shown to reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> volume at 72 hours </plain></SENT>
<SENT sid="1" pm="."><plain>The present study was conducted to examine the treatment time window when <z:chebi fb="9" ids="16796">melatonin</z:chebi> was commenced after <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Adult male Sprague-Dawley rats were anesthetized to undergo right-sided middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 3 hours </plain></SENT>
<SENT sid="3" pm="."><plain>A single intraperitoneal injection of vehicle or <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 mg/kg was given at 0, 1, or 3 hours after <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Other groups received multiple injections of vehicle or <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 mg/kg with the first injection given at 1, 2, or 3 hours after <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and the second and third injections at 24 and 48 hours, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Multiple injections of <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 15 mg/kg with the first injection given at 3 hours were also made </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was determined at 72 hours </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: A single dose of <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 mg/kg given at 0 or 1 but not 3 hours after <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple doses of <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 mg/kg also reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume when the first dose was given at 1 or 2 but not 3 hours after <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Significant hemodynamic effects were not observed </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our results indicate that <z:chebi fb="9" ids="16796">melatonin</z:chebi> at 5 mg/kg given as a single injection or multiple injections protects against focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> when commenced within 2 hours of <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
</text></document>